DOI:
10.1055/s-00025477
International Archives of Otorhinolaryngology
LinksClose Window
References
Barnes JA, Lacasce AS, Feng Y. , et al.
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
Ann Oncol 2011;
22 (08) 1859-1864
We do not assume any responsibility for the contents of the web pages of other providers.